Adaptive by Design: How RTSM Powers Early-Phase Clinical Trial Success

Early-phase clinical trials require precision and agility. Yet, managing protocol changes, patient cohorts and investigational product (IP) supply can quickly become a logistical challenge.

Adaptive trials require faster decision-making and seamless execution. Without the right randomization and trial supply management (RTSM), teams jeopardize both study success and patient safety.

The key to overcoming these challenges is not just automation—it is adaptability. A configurable RTSM evolves with your trial to mitigate risk, improve compliance and prevent costly supply disruptions. When integrated with an eClinical platform, RTSM enhances workflows and efficiency, ensuring trials stay on track.

This webinar explores why a flexible RTSM is essential for early-phase success—and how Medrio’s unified approach makes a difference.

Speakers

  • Ian Davison, RTSM Subject Matter Expert, Medrio
  • Naji Hamim, RTSM Product Owner, Medrio

Complete this form to view this webinar.

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.